Edition:
United States

TapImmune Inc (TPIV.OQ)

TPIV.OQ on NASDAQ Stock Exchange Capital Market

2.91USD
20 Apr 2018
Change (% chg)

$-0.15 (-4.90%)
Prev Close
$3.06
Open
$3.00
Day's High
$3.00
Day's Low
$2.78
Volume
18,255
Avg. Vol
10,223
52-wk High
$4.50
52-wk Low
$2.62

Chart for

About

TapImmune Inc. is an immuno-oncology company. The Company specializes in the development of peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer. The Company is engaged in developing vaccines that target candidate breast cancers, colorectal cancers, ovarian cancers and non-small cell lung cancers.... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): --
Shares Outstanding(Mil.): 10.63
Dividend: --
Yield (%): --

Financials

  TPIV.OQ Industry Sector
P/E (TTM): -- 188.22 33.60
EPS (TTM): -- -- --
ROI: -- -0.74 13.19
ROE: -- -2.80 15.00

BRIEF-Iroquois Capital Management LLC Reports A 5.5 Pct Stake In TapImmune As Of April 4

* IROQUOIS CAPITAL MANAGEMENT LLC REPORTS A 5.5 PCT STAKE IN TAPIMMUNE AS OF APRIL 4 - SEC FILING

Apr 04 2018

BRIEF-Tapimmune Q3 loss earnings per share $0.39‍​

* Tapimmune provides third quarter 2017 corporate and clinical update

Nov 15 2017

Earnings vs. Estimates

No consensus analysis data available.